Matches in SemOpenAlex for { <https://semopenalex.org/work/W1569800470> ?p ?o ?g. }
- W1569800470 endingPage "137" @default.
- W1569800470 startingPage "127" @default.
- W1569800470 abstract "Cancer immunotherapy induces a variety of autoinflammatory responses, including those against the thyroid gland, which can be exploited to predict clinical outcomes. Considering the paucity of information about thyroid autoimmunity in patients receiving cancer vaccines, we designed our study to assess the development of thyroglobulin antibodies (TgAbs) in patients treated with GVAX (vaccine made of a tumor cell type transfected with GM-CSF) and/or ipilimumab and correlated seroconversion with survival. Using both in house and commercial ELISA assays, we measured TgAbs in patients with pancreatic (No. = 53), prostate (No. = 35) or colon (No. = 8) cancer, before and after treatment with GVAX only (No. = 34), GVAX plus ipilimumab (No. = 42) or ipilimumab (No. = 20), and correlated their levels with patient's survival, disease status and T-cell surface markers. Antibodies to thyroperoxidase, myeloperoxidase, proteinase 3, insulin and actin were also measured. TgAbs specifically developed after GVAX, independent of the underlying cancer (81% in prostate, 75% colon cancer and 76% pancreatic cancer) and co-administration of ipilimumab (75% in GVAX only and 78% in GVAX plus ipilimumab). This TgAbs seroconversion could be detected mainly by the in house assay, suggesting that the thyroglobulin epitopes recognized by the antibodies induced by GVAX are different from the epitopes seen in the classic form of Hashimoto thyroiditis. Notably, TgAbs seroconversion was associated with significantly prolonged survival (p = 0.01 for pancreas and p = 0.005 for prostate cancer). In conclusion, GVAX immunotherapy induces the appearance of TgAbs that recognize a unique antigenic repertoire and associate with prolonged survival." @default.
- W1569800470 created "2016-06-24" @default.
- W1569800470 creator A5000868896 @default.
- W1569800470 creator A5001768193 @default.
- W1569800470 creator A5011334545 @default.
- W1569800470 creator A5011776853 @default.
- W1569800470 creator A5032553128 @default.
- W1569800470 creator A5033720986 @default.
- W1569800470 creator A5036730014 @default.
- W1569800470 creator A5039147214 @default.
- W1569800470 creator A5039709555 @default.
- W1569800470 creator A5050642902 @default.
- W1569800470 creator A5053105927 @default.
- W1569800470 creator A5055145325 @default.
- W1569800470 creator A5058389360 @default.
- W1569800470 creator A5060335470 @default.
- W1569800470 creator A5072068921 @default.
- W1569800470 creator A5078707780 @default.
- W1569800470 date "2014-05-28" @default.
- W1569800470 modified "2023-10-05" @default.
- W1569800470 title "Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival" @default.
- W1569800470 cites W111301829 @default.
- W1569800470 cites W1823669223 @default.
- W1569800470 cites W1909858390 @default.
- W1569800470 cites W1967360230 @default.
- W1569800470 cites W1979446115 @default.
- W1569800470 cites W1981288213 @default.
- W1569800470 cites W1987384630 @default.
- W1569800470 cites W1988065950 @default.
- W1569800470 cites W1989675500 @default.
- W1569800470 cites W1991148746 @default.
- W1569800470 cites W1994830891 @default.
- W1569800470 cites W2012032758 @default.
- W1569800470 cites W2017921889 @default.
- W1569800470 cites W2020649972 @default.
- W1569800470 cites W2021703644 @default.
- W1569800470 cites W2022073464 @default.
- W1569800470 cites W2025218620 @default.
- W1569800470 cites W2027591337 @default.
- W1569800470 cites W2036392773 @default.
- W1569800470 cites W2039863086 @default.
- W1569800470 cites W2065207101 @default.
- W1569800470 cites W2075936080 @default.
- W1569800470 cites W2109465910 @default.
- W1569800470 cites W2109653150 @default.
- W1569800470 cites W2114657480 @default.
- W1569800470 cites W2117089606 @default.
- W1569800470 cites W2119198740 @default.
- W1569800470 cites W2124757685 @default.
- W1569800470 cites W2125200037 @default.
- W1569800470 cites W2126365735 @default.
- W1569800470 cites W2130846254 @default.
- W1569800470 cites W2133977411 @default.
- W1569800470 cites W2141393790 @default.
- W1569800470 cites W2143224749 @default.
- W1569800470 cites W2152155935 @default.
- W1569800470 cites W2164731084 @default.
- W1569800470 cites W2168718152 @default.
- W1569800470 cites W2172131454 @default.
- W1569800470 cites W2324865626 @default.
- W1569800470 cites W28734780 @default.
- W1569800470 cites W4256189622 @default.
- W1569800470 doi "https://doi.org/10.1002/ijc.28973" @default.
- W1569800470 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4199892" @default.
- W1569800470 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24832153" @default.
- W1569800470 hasPublicationYear "2014" @default.
- W1569800470 type Work @default.
- W1569800470 sameAs 1569800470 @default.
- W1569800470 citedByCount "34" @default.
- W1569800470 countsByYear W15698004702015 @default.
- W1569800470 countsByYear W15698004702016 @default.
- W1569800470 countsByYear W15698004702017 @default.
- W1569800470 countsByYear W15698004702018 @default.
- W1569800470 countsByYear W15698004702019 @default.
- W1569800470 countsByYear W15698004702020 @default.
- W1569800470 countsByYear W15698004702021 @default.
- W1569800470 countsByYear W15698004702022 @default.
- W1569800470 crossrefType "journal-article" @default.
- W1569800470 hasAuthorship W1569800470A5000868896 @default.
- W1569800470 hasAuthorship W1569800470A5001768193 @default.
- W1569800470 hasAuthorship W1569800470A5011334545 @default.
- W1569800470 hasAuthorship W1569800470A5011776853 @default.
- W1569800470 hasAuthorship W1569800470A5032553128 @default.
- W1569800470 hasAuthorship W1569800470A5033720986 @default.
- W1569800470 hasAuthorship W1569800470A5036730014 @default.
- W1569800470 hasAuthorship W1569800470A5039147214 @default.
- W1569800470 hasAuthorship W1569800470A5039709555 @default.
- W1569800470 hasAuthorship W1569800470A5050642902 @default.
- W1569800470 hasAuthorship W1569800470A5053105927 @default.
- W1569800470 hasAuthorship W1569800470A5055145325 @default.
- W1569800470 hasAuthorship W1569800470A5058389360 @default.
- W1569800470 hasAuthorship W1569800470A5060335470 @default.
- W1569800470 hasAuthorship W1569800470A5072068921 @default.
- W1569800470 hasAuthorship W1569800470A5078707780 @default.
- W1569800470 hasBestOaLocation W15698004701 @default.
- W1569800470 hasConcept C121608353 @default.
- W1569800470 hasConcept C126322002 @default.
- W1569800470 hasConcept C143998085 @default.